SCHEMBL7303017

SCHEMBL7303017

CCOC(=O)N(CCCCN1CC=C(c2ccccc2)CC1)c1cccc([N+](=O)[O-])c1C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.39
HRH2 P25021 1/20 0.38
HRH1 P35367 1/20 0.38
KDM4E B2RXH2 3/20 0.38
TDP1 Q9NUW8 2/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
PPARG P37231 1/20 0.37
PPARA Q07869 1/20 0.37
HTR1A P08908 2/20 0.37
DRD4 P21917 2/20 0.37
ALOX15 P16050 1/20 0.37
APEX1 P27695 1/20 0.37
KMT2A Q03164 1/20 0.37
HSD17B10 Q99714 1/20 0.37
DRD3 P35462 1/20 0.36
HTR7 P34969 2/20 0.36
PARP1 P09874 1/20 0.36
HTR2A P28223 1/20 0.36
ADRA1A P35348 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7310797 0.93 DRD3 (0.38) SIGMAR1HRH2HRH1KDM4ETDP1
SCHEMBL7308008 0.88 SIGMAR1 (0.42) SIGMAR1KDM4ETDP1ALDH1A1MAPT
SCHEMBL7310638 0.87 KDM4E (0.43) SIGMAR1KDM4ETDP1ALDH1A1MAPT
SCHEMBL7307713 0.86 HTR7 (0.44) SIGMAR1KDM4ETDP1ALDH1A1MAPT
SCHEMBL7305724 0.83 DRD3 (0.39) SIGMAR1KDM4ETDP1ALDH1A1MAPT
SCHEMBL7310926 0.83 TP53 (0.41) SIGMAR1HRH2HRH1KDM4ETDP1
SCHEMBL7297468 0.83 DRD3 (0.41) SIGMAR1KDM4ETDP1ALDH1A1MAPT
SCHEMBL7307166 0.83 KDM4E (0.43) SIGMAR1KDM4ETDP1ALDH1A1MAPT
SCHEMBL7302447 0.81 PARP1 (0.42) SIGMAR1KDM4ETDP1ALDH1A1MAPT
SCHEMBL7301503 0.81 HTR7 (0.43) SIGMAR1KDM4ETDP1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5304560-A Treating CNS disorders; dopamine receptor antagonist FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-04-19 US disclosed
CN-1060841-A Quinazoline derivant and preparation method thereof FUJISAWA PHARMACEUTICAL CO (JP) 1992-05-06 CN disclosed
EP-0481342-A1 Quinazoline derivatives and their preparation FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-04-22 EP disclosed